First Trust Advisors LP Immunocore Holdings PLC Transaction History

First Trust Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$49.5 - $66.6 $255,123 - $343,256	-5,154 Reduced 20.63%	19,826 $1.03 Million
Q2 2023 Aug 14, 2023	BUY	$48.54 - $61.64 $1.21 Million - $1.54 Million	24,980 New	24,980 $1.5 Million
Q4 2022 Feb 09, 2023	BUY	$45.51 - $65.08 $636,002 - $909,493	13,975 New	13,975 $797,000

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.